Germline variant affecting p53β isoforms predisposes to familial cancer

Stephanie A. Schubert, Dina Ruano, Sebastien M. Joruiz, Jordy Stroosma, Nikolina Glavak, Anna Montali, Lia Pinto, Mar Rodríguez-Girondo, Daniela Q. C. M. Barge-Schaapveld, Maartje Nielsen, Bernadette P. M. van Nesselrooij, Arjen R. Mensenkamp, Monique E. van Leerdam, Thomas H. Sharp, Hans Morreau, Jean-Christophe Bourdon (Lead / Corresponding author), Noel F. C. C. de Miranda (Lead / Corresponding author), Tom van Wezel (Lead / Corresponding author)

Research output: Contribution to journalArticlepeer-review

20 Downloads (Pure)

Abstract

Germline and somatic TP53 variants play a crucial role during tumorigenesis. However, genetic variations that solely affect the alternatively spliced p53 isoforms, p53β and p53γ, are not fully considered in the molecular diagnosis of Li-Fraumeni syndrome and cancer. In our search for additional cancer predisposing variants, we identify a heterozygous stop-lost variant affecting the p53β isoforms (p.*342Serext*17) in four families suspected of an autosomal dominant cancer syndrome with colorectal, breast and papillary thyroid cancers. The stop-lost variant leads to the 17 amino-acid extension of the p53β isoforms, which increases oligomerization to canonical p53α and dysregulates the expression of p53’s transcriptional targets. Our study reveals the capacity of p53β mutants to influence p53 signalling and contribute to the susceptibility of different cancer types. These findings underscore the significance of p53 isoforms and the necessity of comprehensive investigation into the entire TP53 gene in understanding cancer predisposition.
Original languageEnglish
Article number8208
Number of pages15
JournalNature Communications
Volume15
DOIs
Publication statusPublished - 18 Sept 2024

Fingerprint

Dive into the research topics of 'Germline variant affecting p53β isoforms predisposes to familial cancer'. Together they form a unique fingerprint.

Cite this